FDA Adverse Event Injury Summary report: N

CHLORAPREP UNKNOWN

MDR report key: 11910749 · Received May 31, 2021

Report

Report Number
3004932373-2021-00262
Event Type
Injury
Date Received
May 31, 2021
Date of Event
May 12, 2021
Report Date
May 20, 2021
Manufacturer
CAREFUSION 213, LLC 0113
Product Code
OJU
PMA / PMN Number
EXEMPT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4) INITIAL EMDR SUBMISSION. A FOLLOW UP EMDR WILL BE SUBMITTED IF ADDITIONAL INFORMATION BECOMES AVAILABLE. (B)(4). NO ADDITIONAL INFORMATION WAS PROVIDED BY THE MHRA. PRIMEVIGILANCE DID REACH OUT TO OBTAIN MORE INFORMATION WITH NO SUCCESS. SHOULD ADDITIONAL INFORMATION BE AVAILABLE IN THE FUTURE, THE COMPLAINT WILL BE RE-OPENED AND INVESTIGATED. ALL COMPLAINTS ARE REVIEWED DURING MONTHLY QUALITY/SAFETY MEETINGS. IN ADDITION, COMPLAINTS ARE TRENDED AT MONTHLY QUALITY DATA ANALYST MEETINGS AND QUARTERLY PLANT MANAGEMENT REVIEW MEETINGS.

Description of Event or Problem · 1

IT WAS REPORTED BY THE HEALTH AUTHORITY THAT THE PATIENT EXPERIENCED APPLICATION SITE RASH. APPLICATION SITE RASH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
803274 CHLORAPREP UNKNOWN 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL OJU CAREFUSION 213, LLC 0113 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 5 YR Other